Incidence of adverse events during treatment with verapamil for suspected acute myocardial infarction
- 15 December 1992
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (20) , 1611-1612
- https://doi.org/10.1016/0002-9149(92)90468-e
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- “Cardioprotection” — Not all calcium antagonists are created equalThe American Journal of Cardiology, 1990
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Myocardial salvage with streptokinase combined with nitroglycerine and verapamil in acute myocardial infarctionInternational Journal of Cardiology, 1988
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2Published by Elsevier ,1988
- Combined effects of calcium antagonists and nitroglycerin on large coronary artery diameterAmerican Heart Journal, 1988
- Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1986
- Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamilThe American Journal of Cardiology, 1984
- Verapamil in acute myocardial infarctionEuropean Heart Journal, 1984
- Effects of verapamil in patients with acute myocardial infarction: Hemodynamics and function of normal and ischemic left ventricular myocardiumAmerican Heart Journal, 1984